CURRICULUM VITAE - Shiraz Pharmacy School

89. Sadeghpour, H., Jalilian, A.R., Akhlaghi, M., Shafiee, S., Mirzaii, M., Miri, R., Saddadi, F. (2008) "Biologicalevaluation of [18F]-nifedipine as a novel PET tracer for L-type calciumchannel imaging" Nukleonika, 53, 151−154.90. Foroghinia, F., Javidnia, K., Amirghofran, Z., Medipour, A.R., Miri, R. (2008) “Design and synthesis and of newderivatives of dihydropyridine containing a pyrigyl group on 3,5-positions and evaluation of their cytotoxic and multidrugresistance reversal activity” J. Pharm. Pharmacol., 60, 1481-1489.91. Javidnia, K., Miri, R., Soltani, M., Gholami, M., Khosravi, A.R. (2008)”Antimicrobial activity and chemicalcomposition of the essential oils of six Iranian Salvia L. species” Chem. Natural Comp., 44, 529-531.92. Khoshneviszadeh, M., Edraki, N., Miri, R., Hemmateenejad, B., (2008) “Exploring QSAR for substituted 2-sulfonylphenyl-indolderivatives as potent and selective COX-2 inhibitors using different chemometrics tools” Chem. Biol. DrugDes., 72, 564-574.93. Javidnia, K., Miri, R., Soltani, M., Khosravi, A. R. (2008) “Essential oil composition of Tripleurospermumdisciforme from Iran” Chem. Natural Comp., 44, 800-801.94. Sadeghpour, H., Jalilian, A.R., Shafiee, S., Akhlaghi, M., Miri, R., Mirzaii, M. (2008) "Radiosynthesis of dimethyl-2-[18F]-(fluoromethyl)-6-methyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate for L-type calcium channelimaging" Radiochim. Acta, 96, 849-853.95. Miri, R., Javidnia, K., Mirkhani, H., Hemmateenejad, B., Kazemi, Z., Edraki, N., Mehdipour. A.R. (2008) “Synthesisand in vitro dual calcium channel antagonist-agonist activity of some 1, 4- Dihydo-2, 6-dimethyl-3-nitro and cyano- 4- (1-methyl- 5-nitroimidazole-2-yl)-5- pyridinecarboxylates” Daru, 16, 263-269.96. Javidnia, K., Miri, R., Soltani, M., Khosravi, A.R. (2008) “Constituents of the essential oil of Pycnocycla nodifloraDecne. Ex Boiss. from Iran” J. Essent. Oil Res. 20, 502-504.97. Javidnia, K., Miri, R., Soltani, M., Khosravi, A. R. (2009) “Essential oil composition of Tanacetum bachtiaricumfrom Iran” ” Chem. Natural Comp., 802-804.98. Javidnia, K., Miri, R., Soltani, M., Varamini, P. (2009) “Volatile constiruents of two species of Haplophyllum A.Juss. From Iran [H. lissonotum C. Town. and H. buxbaumii (Poir.) G. subsp. mesopotamicum (Boiss.) C. Town.]” J.Essent. Oil Res., 21, 48-51.99. Javidnia, K., Miri, R., Soltani, M., Khosravi, A.R. (2009) “Essential oil composition of two Iranian endemicHelichrysum Miller. species (H. leucocephalum Boiss. and H. artemisioides Boiss & Hausskn.)” J. Essent. Oil Res., 21, 54-56.100. Miri, R., Javidnia, K., Hemmateenejad, B., Tabarzad, M., Jafarpour, M., (2009) “Synthesis, evaluation ofpharmacological activities and QSAR studies of a novel group of bis(4-nitroaryl-1,4- Dihyropyridine) “Chem. Biol. DrugDes. 73, 225-235.101. Koshneviszadeh, M., Edraki, N., Javidnia, K., Alborzi, A., Pourabaas, B., Mardaneh, J., Miri, R. (2009) "Design,synthesis and biological evaluation of some new 1, 4-dihydropyridines containing different ester substitute and diethylcarbamoyl group as antitubercular agents" Bioorg. Med. Chem., 17, 1579-1586.102. Hemmateenejad, B., Miri, R., Kamali, R. (2009) “A kinetic spectrophotometric method for determination ofAmlodipine and Nifedipine in pharmaceutical preparations” J. Iranian Chem. Soc., 6, 113-120.103. Samzadeh-Kermani, A., Shafaroodi, H., Miri, R., Mirkhani, H., Vosiighi, M., Shafiee, A. (2009) “lipophilic 2-(4-chiorophenyl)-4-thiazolyl-1,4-dihydropyridines: Synthesis, calcium channel antagonist activity and protection againstpentylenetetrazol-induce seizure” Med. Chem, Res., 18, 112-126.104. Amirghofran, Z., Bahmani, M., Azadmehr, A., Javidnia, K., Miri, R. (2009) “Immunomodulatory activities ofvarious medicinal plant extracts: effects on human lymphocytes apoptosis” Immunol. Invest., 38, 181-192.105. Javidnia, K., Aram, F., Solouki, M., Mehdipour, A.R., Golami, M., Miri, R. (2009) “Microbial biotransformation ofsome monoterpene hydrocarbons” Annals of Microbiol., 59, 1-3.106. Hemmateenejad, B., Mehdipour, A.R., Miri, R., Shamsipur, M. (2009) "Application of MOLMAP approach forQSAR modeling of various biological activities using substituent electronic descriptors" J. Comput. Chem., 30, 2001-2009.107. Nekooeian, A.A., Khalili, A., Javidnia, K., Mehdipour, A.R., Miri, R., (2009) “Antihypertensive effects of somenew nitroxyalkyl 1,4-dihydropyridines derivatives in rat model of two-kidney, one-clip hypertension” Iranian J. Pharm..Res. 8, 193-199.108. Fassihi, A., Azadpour, Z., Delbari, N., Saghaie, L., Memarian, H.R., Sabet, R., Alborzi, A., Miri, R., Pourabbas, B.,Mardaneh, J., Mousavi, P., Moeinifard, B., Sadeghi-aliabadi, H. (2009) “Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl- 1,4-dihydropyridine-3,5-dicarboxamides” European J. Med. Chem.,44, 3253-3258.109. Bahmani, M.K., Khosravi, A., Miri, R., Iwabu, Y., Ikuta, K., Sakudo, A. (2009) “Spectroscopic characterization ofhuman immunodeficiency virus type-1-infected plasma by principal component analysis and soft independent modeling ofclass analogy of visible and near-infrared spectra” Molecular Medicine Report, 2, 805-809.110. Edraki, N., Mehdipour, A.R., Khoshneviszadeh, M., Miri, R. (2009) “Dihydropyridines: evalurtion of their currentand future pharmacological applicarions” Drug Discovery Today, 14, 1058-1066.